Cowen And Company, LLC Tricida, Inc. Transaction History

Cowen And Company, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	SELL	$0.14 - $12.49 $1,930 - $172,224	-13,789 Reduced 51.85%	12,806 $1,000
Q3 2022 Nov 14, 2022	BUY	$8.51 - $13.6 $225,642 - $360,604	26,515 Added 33143.75%	26,595 $92,000
Q2 2022 Aug 05, 2022	BUY	$7.31 - $11.85 $584 - $948	80 New	80 $1,000

30K

124K

46.5K

Ticker TCDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,668,900
Market Cap $557K
Description
Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Cowen And Company, LLC with notifications on news.